BAGSVAERD, DENMARK--(Marketwire - August 05, 2010) -
Novo Nordisk increased operating profit by 19% in the first half of 2010
Sales growth of 14% driven by modern insulins and Victoza(r)
[HUG#1435910]
Company Announcement no 43 2010:
http://hugin.info/2013/R/1435910/381105.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Novo Nordisk A/S via Thomson Reuters ONE
